Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Bartholomew

Showing results (81-90 of 191) with videos related to

Pageof 20
Sort By:
Vascular Medicine (London, England)|January 4, 2024
Images in Vascular Medicine: Mondor's disease due to high-output arteriovenous fistulaSyed Bukhari, Ammar Saati, Geoffrey Ouma, et al.
Vascular Medicine (London, England)|December 16, 2023
Images in Vascular Medicine: Nonuremic calciphylaxis secondary to occult malignancySyed Bukhari, Mohamed Ghoweba, John R Bartholomew, et al.
Diagnostic Microbiology and Infectious Disease|December 1, 1988
Neisseria meningitidis and Moraxella osloensis: dual infection in blood and peritoneal fluidL L Tiosejo, M Hocko, W R Bartholomew, et al.
Clinical Therapeutics|May 4, 2010
Rationale and design of the PREVENT-HIT study: a randomized, open-label pilot study to compare desirudin and argatroban in patients with suspected heparin-induced thrombocytopenia with or without thrombosisJames N Frame, Lawrence Rice, John R Bartholomew, et al.
Nuclear Medicine Communications|June 1, 1994
Non-covalent antibody-mediated drug deliveryC Lollo, S Halpern, R Bartholomew, et al.
Cleveland Clinic Journal of Medicine|April 27, 2005
Varicose veins: newer, better treatments availableJohn R Bartholomew, Terry King, Avisesh Sahgal, et al.
Cleveland Clinic Journal of Medicine|December 3, 2009
An algorithm for managing warfarin resistanceOlusegun Osinbowale, Monzr Al Malki, Andrew Schade, et al.
Cancer Communications|January 1, 1991
Antibody-mediated delivery of tumor necrosis factor (TNF-alpha): improvement of cytotoxicity and reduction of cellular resistanceM G Rosenblum, L Cheung, J L Murray, et al.
Missouri Medicine|September 1, 1995
Are serum levels of vancomycin useful in the first week of therapy?E Goldstein, W R Bartholomew, M K Vickers, et al.
Cleveland Clinic Journal of Medicine|July 1, 2024
Lymphedema vs lipedema: Similar but differentLaura Daniela Lomeli, Vinni Makin, John R Bartholomew, et al.
Pageof 20

Showing results (81-90 of 191) with videos related to

Sort By:
Pageof 20
Vascular Medicine (London, England)|January 4, 2024
Images in Vascular Medicine: Mondor's disease due to high-output arteriovenous fistulaSyed Bukhari, Ammar Saati, Geoffrey Ouma, et al.
Vascular Medicine (London, England)|December 16, 2023
Images in Vascular Medicine: Nonuremic calciphylaxis secondary to occult malignancySyed Bukhari, Mohamed Ghoweba, John R Bartholomew, et al.
Diagnostic Microbiology and Infectious Disease|December 1, 1988
Neisseria meningitidis and Moraxella osloensis: dual infection in blood and peritoneal fluidL L Tiosejo, M Hocko, W R Bartholomew, et al.
Clinical Therapeutics|May 4, 2010
Rationale and design of the PREVENT-HIT study: a randomized, open-label pilot study to compare desirudin and argatroban in patients with suspected heparin-induced thrombocytopenia with or without thrombosisJames N Frame, Lawrence Rice, John R Bartholomew, et al.
Nuclear Medicine Communications|June 1, 1994
Non-covalent antibody-mediated drug deliveryC Lollo, S Halpern, R Bartholomew, et al.
Cleveland Clinic Journal of Medicine|April 27, 2005
Varicose veins: newer, better treatments availableJohn R Bartholomew, Terry King, Avisesh Sahgal, et al.
Cleveland Clinic Journal of Medicine|December 3, 2009
An algorithm for managing warfarin resistanceOlusegun Osinbowale, Monzr Al Malki, Andrew Schade, et al.
Cancer Communications|January 1, 1991
Antibody-mediated delivery of tumor necrosis factor (TNF-alpha): improvement of cytotoxicity and reduction of cellular resistanceM G Rosenblum, L Cheung, J L Murray, et al.
Missouri Medicine|September 1, 1995
Are serum levels of vancomycin useful in the first week of therapy?E Goldstein, W R Bartholomew, M K Vickers, et al.
Cleveland Clinic Journal of Medicine|July 1, 2024
Lymphedema vs lipedema: Similar but differentLaura Daniela Lomeli, Vinni Makin, John R Bartholomew, et al.
Pageof 20